Compare ACADIA Pharmaceuticals Inc. (ACAD) vs AFLAC Incorporated (AFL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ACADIA Pharmaceuticals Inc. vs AFLAC Incorporated — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.45 (market cap $5.07B), while AFLAC Incorporated trades at $121.06 (market cap $60.70B). The key difference: AFLAC Incorporated is far larger — about 12× ACADIA Pharmaceuticals Inc.'s market cap, and AFLAC Incorporated pays a 2.02% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | AFL | |
|---|---|---|
Market Cap | $5.07B | $60.70B |
Sector | Health | Financials |
52-Week High | $29.41 | $129.55 |
52-Week Low | $20.06 | $103.55 |
Enterprise Value | $4.19B | $70.65B |
Dividend Yield | — | 2.02% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →About AFLAC Incorporated
Aflac Inc offers supplemental health insurance and life insurance in the two largest insurance markets in the world, the U.S. and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accidents, disability, and long-term-care insurance. It markets its products through independent distributors, selling most of its policies directly to consumers at their places of work.
Read more on AFL →
